Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Bibliografski detalji
Glavni autori:	Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
Format:	Journal article
Izdano:	2009

Slični predmeti

FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer
od: Griffiths, G, i dr.
Izdano: (2009)

FRAGMATIC: A randomised phase III clinical trial investigating the effect of <b>fragm</b>in<sup>® </sup><b>a</b>dded to standard <b>t</b>herapy <b>i</b>n patients with lung <b>c</b>ancer
od: Macbeth Fergus R, i dr.
Izdano: (2009-10-01)

Releasing interim results from a randomised clinical trial: an example from the QUARTZ trial
od: Nankivell Matthew, i dr.
Izdano: (2011-12-01)

Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
od: Dong Qian, i dr.
Izdano: (2015-01-01)

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial
od: Anders Kjellberg, i dr.
Izdano: (2023-01-01)

Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis
od: Ken Haruma, i dr.
Izdano: (2023-05-01)

Issues in data monitoring and interim analysis of trials.
od: Grant, A, i dr.
Izdano: (2005)

CANparent trial evaluation: second interim report
od: Cullen, M, i dr.
Izdano: (2014)

CANparent trial evaluation: First interim report
od: Cullen, M, i dr.
Izdano: (2013)

Guidance on interim analysis methods in clinical trials
od: Jody D. Ciolino, i dr.
Izdano: (2023-01-01)

Issues in data monitoring and interim analysis of trials
od: A Grant, i dr.
Izdano: (2005-03-01)

Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial
od: Masahide Oki, i dr.
Izdano: (2024-12-01)

Impact of theta burst stimulation on face processing in autism: Interim results from a randomised controlled trial
od: Briella Rodriguez, i dr.
Izdano: (2025-01-01)

Efficacy of Biosilicate Glass-Ceramic and Gluma in the Treatment of Cervical Dentin Hypersensitivity: An Interim Results of Randomised Control Trial
od: Maria Luiza Lima Santana, i dr.
Izdano: (2022-04-01)

Decision on performing interim analysis for comparative clinical trials
od: Kyongsun Pak, i dr.
Izdano: (2017-09-01)

Approaches to interim analysis of cancer randomised clinical trials with time to event endpoints: A survey from the Italian National Monitoring Centre for Clinical Trials
od: De Rosa Marisa, i dr.
Izdano: (2008-07-01)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
od: Voysey, M, i dr.
Izdano: (2020)

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer
od: Crosby, T, i dr.
Izdano: (2017)

Monitoring clinical trials. Interim data should not be publicly available.
od: Richards, S
Izdano: (2001)

Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial
od: Shaji Sebastian, i dr.
Izdano: (2024-07-01)

Using an integrated motor imagery and physical training intervention after knee injury: an interim analysis of the MOTIFS randomised controlled trial
od: Eva Ageberg, i dr.
Izdano: (2024-10-01)

Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results
od: María Jesús López Fernández, i dr.
Izdano: (2024-07-01)

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
od: Samuel Ponce-de-León, i dr.
Izdano: (2023-05-01)

Prospective randomized controlled trial comparing the efficacy and safety of Roux-en-Y gastric bypass and one-anastomosis gastric bypass (the RYSA trial): trial protocol and interim analysis
od: Tuure Saarinen, i dr.
Izdano: (2019-12-01)

Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
od: Giuseppe Fiorentino, i dr.
Izdano: (2022-09-01)

Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
od: Keiji Hirai, i dr.
Izdano: (2017-06-01)

A single injection of zoledronic acid may prevent bone loss after stroke: Planned interim analysis of a randomised trial
od: Poole, K, i dr.
Izdano: (2004)

Selective versus stepwise removal of deep carious lesions in permanent teeth: a randomised controlled trial from Egypt—an interim analysis
od: Falk Schwendicke, i dr.
Izdano: (2019-09-01)

Children Anxiety and Pain while Performing Interim Therapeutic Restorations with Hand Instruments compared to Rotary Instruments: A Randomised Clinical Trial
od: Osama M Felemban, i dr.
Izdano: (2024-01-01)

Comparison of neutral and lowered shoulder position on successful right subclavian vein catheterisation in children: An interim analysis of a randomised controlled trial
od: Dhirendra Pratap Singh, i dr.
Izdano: (2018-01-01)

Azathioprine in ulcerative colitis: an interim report on a controlled therapeutic trial.
od: Jewell, D, i dr.
Izdano: (1972)

THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES
od: M. V. Shestakova, i dr.
Izdano: (2016-05-01)

The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues
od: Editorial team Diabetes Mellitus
Izdano: (2016-05-01)

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers
od: Kathleen A. Welsh‐Bohmer, i dr.
Izdano: (2023-10-01)

Interim analysis: A rational approach of decision making in clinical trial
od: Amal Kumar, i dr.
Izdano: (2016-01-01)

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial
od: Jensen Alexandra D, i dr.
Izdano: (2012-04-01)

Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial
od: Marit S. van Sandwijk, MD, i dr.
Izdano: (2018-06-01)

Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial
od: Thuy P. Nguyen, i dr.
Izdano: (2022-07-01)

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial
od: Punnee Pitisuttithum, i dr.
Izdano: (2022-03-01)

Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial
od: Anders Kvanta, i dr.
Izdano: (2024-09-01)